Dash Bio
Boston, US · Founded 2024 · Delaware corporation · 4 known investors
Dash Bio is a contract research organization (CRO) offering bioanalysis services with a technology-based, automated approach, delivering sample analysis results in days. It provides method development and validation, ELISA/MSD, LC-MS, and qPCR assays across preclinical to late-stage clinical studies for pharmaceutical and biotech companies.
AI & Machine LearningBiotechHealthtechRobotics
Founders & leadership
Dash Bio was founded in 2024 by Dave Johnson.
Board
AS
Investors · 4
Reported raises · per SEC filings
Form D private placements$47.1M disclosed across 3 rounds · 2024–2026
▶$30MraisedJul 2026 · 9 investors · Other Health CareRule 506(b)
▶$30MraisedJul 2026 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David JohnsonExecutive Officer, Director
- Alexander TallettExecutive Officer, Director
- Andy SmithDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$11MraisedJun 2025 · 12 investors · BiotechnologyRule 506(b)
▶$11MraisedJun 2025 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ALEXANDER TALLETTExecutive Officer, Director
- DAVID JOHNSONExecutive Officer, Director
- Amount sold
- $11M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
▶$6.1MraisedOct 2024 · 15 investors · BiotechnologyRule 506(b)
▶$6.1MraisedOct 2024 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- DAVID JOHNSONExecutive Officer, Director
- ALEXANDER TALLETTExecutive Officer, Director
- Amount sold
- $6.1M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapPlotly14 shared keywordsPlotly builds data visualization and analytics tools, including the open-source libraries Plotly.js, Plotly.py, and Dash, plus commercial products Dash Enterprise, Plotly Studio, and Plotly Cloud. Its AI-native Plotly Studio platform lets analysts, researchers, and enterprise teams turn raw data into interactive applications and dashboards.
Dash Privacy Currency11 shared keywordsDash is a cryptocurrency and payment network for sending money globally, offering instant, low-cost, and private transactions through mobile and desktop wallets such as DashCore and DashPay. It targets everyday users seeking a simple way to send and receive digital currency across borders.
DoorDash7 shared keywordsDoorDash operates a restaurant delivery platform that connects customers with dining establishments across hundreds of cities in North America through a logistics network.
Dash Water7 shared keywordsDASH makes zero-sugar soft drinks produced from surplus "wonky" fruit sourced from UK farmers to reduce food waste. The company is a certified B Corp operating in the beverage market.
Companies competing with Dash Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Dash Bio Raises $30M in Series A Fundingfinsmes.com · Aug 2026Frequently asked questions
- What does Dash Bio do?
- Dash Bio is a contract research organization (CRO) offering bioanalysis services with a technology-based, automated approach, delivering sample analysis results in days. It provides method development and validation, ELISA/MSD, LC-MS, and qPCR assays across preclinical to late-stage clinical studies for pharmaceutical and biotech companies.
- Who founded Dash Bio?
- Dash Bio was founded by Dave Johnson in 2024.
- Who are Dash Bio's investors?
- Dash Bio's investors include LifeX Ventures, Oak HC/FT, Swift Ventures, Freestyle Capital.
- How much funding has Dash Bio raised?
- Dash Bio has disclosed $47.1M raised across 3 rounds.
- Where is Dash Bio headquartered?
- Dash Bio is headquartered in Boston, US.